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The purpose from this study was to investigate the consequences of sensory neurocompensation to
carotid balloon injury in diabetic rats on angiotensin II-induced contraction and basal blood ﬂow in
contralateral carotid. Concentration-response curves for angiotensin II and blood ﬂow were obtained in
contralateral carotid from non-treated or capsaicin-treated streptozotocin-induced diabetic rats that
underwent carotid balloon injury. Diabetes increased angiotensin II-induced contraction and impaired
the blood ﬂow in non-operated rat carotid. In diabetic rats, balloon injury led to neointima formation,
which reduced the blood ﬂow in ipsilateral carotid. Carotid balloon injury in diabetic rats reduced
angiotensin II-induced contraction and restored the blood ﬂow in contralateral carotid when compared
to diabetic non-operated rat carotid. Capsaicin inhibited the effects evoked by carotid balloon injury on
diabetic rat contralateral carotid. Endothelium removal, PEG-catalase (hydrogen peroxide scavenger) or L-
NPA (neuronal nitric oxide synthase, nNOS, inhibitor) increased angiotensin II-induced contraction in
contralateral carotid from diabetic operated rats to the levels observed in diabetic non-operated rat
carotid. Our ﬁndings suggest that carotid balloon injury in diabetic rats elicits a neurocompensation that
attenuates the diabetic hyperreactivity to angiotensin II in contralateral carotid by a sensory nerves-
dependent mechanism mediated by hydrogen peroxide derived from endothelial nNOS. This sensory
mechanism also restored the blood ﬂow in this vessel, compensating the impaired blood ﬂow in diabetic
rat ipsilateral carotid. Thus, our major conclusions are that Diabetes confers a vasoprotective signiﬁcance
to the neurocompensation to carotid balloon injury in preventing further damage at carotid cerebral
irrigation after angioplasty in diabetic subjects.
& 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Type I-Diabetes is an important risk factor for carotid athero-
sclerosis, which can impair cerebral irrigation and lead to stroke
(Gül et al., 2010; Polak et al., 2011). Balloon angioplasty has been
effectively used to restore blood ﬂow in atheromatous carotid
from diabetic patients (Brown, 2001). However, its beneﬁcial
outcomes have been limited by post-angioplasty complications
(Pernomian et al., 2011), which has been widely studied trough
balloon catheter injury model in rat carotid. In this model, the
introduction of balloon catheter into carotid leads to endothelial: þ55 163602 4880.
er OA license.denudation and medial disruption, so that the injured artery is
called ipsilateral carotid (Clowes et al., 1983).
Until 1997, researchers often used contralateral (non-injured)
carotid as the control parameter for ipsilateral carotid, since none
morphological change had been described for contralateral artery
(Antonaccio et al., 1994). But in 1997, Milner et al. observed
that balloon injury reduces the expression of sensory nerves in
ipsilateral carotid, which triggers a neurocompensatory response
that increases these nerves expression in contralateral carotid.
Thereafter, our laboratory showed that the neurocompensatory
response to balloon injury increases angiotensin II-induced con-
traction in contralateral carotid without changing its blood ﬂow
(Accorsi-Mendonça et al., 2004). The contractile hyperreactivity to
angiotensin II in contralateral carotid is important to compensate
the hyporesponsiveness of ipsilateral carotid to angiotensin II,
while the normal blood ﬂow in contralateral artery compensates
Table 1
Fasting blood glucose levels from intact no treated, vehicle- or STZ-treated rats.
Groups Glucose level (mg/dl)
Day 0 Day 2
No treated (normoglycaemic) 79.373.62 77.471.24
Vehicle-treated 75.472.95 80.773.41
STZ-treated (diabetic) 81.171.68 364.777.43a,b
Data represent the mean7S.E.M. (n¼11).
a Signiﬁcant difference (Po0.001) from the no treated group at the same day.
b Signiﬁcant difference (Po0.001) from the no treated group at the same group
at day 0.
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(Accorsi-Mendonça et al., 2004), which avoids further damages
in carotid cerebral irrigation.
Although these ﬁndings point a pathophysiological signiﬁcance
to compensatory response elicited by balloon injury in carotid
cerebral irrigation, they represent a phenomenon that occurs only
in healthy conditions. Usually, clinical carotid angioplasty is
performed in disease conditions characterized by vascular dys-
function, such as Diabetes (Brown, 2001). Furthermore, type
I-Diabetes induces the loss of sensory perivascular innervation
(Cellek et al., 2005; Sima, 2006), which mediates the neurocom-
pensatory response to balloon injury (Milner et al., 1997). Based on
these, we hypothesized that type I-Diabetes would abrogate the
neurocompensatory response to carotid balloon injury. Consider-
ing that type I-Diabetes promotes a higher increase in angiotensin
II-induced contraction in rat carotid (Pernomian et al., 2012) than
that one induced by neurocompensatory response to balloon
injury (Accorsi-Mendonça et al., 2004), we also hypothesized that
the abrogation of this neuronal mechanism would keep the
diabetic hyperreactivity to angiotensin II in contralateral carotid,
which could be enough to impair the local blood ﬂow. According
to this hypothesis, the impaired blood ﬂow in contralateral carotid,
added to the reduced ipsilateral carotid ﬂow, could lead to further
damage in carotid cerebral irrigation after angioplasty during type
I-Diabetes. Thus, we aimed to investigate the consequences of
balloon injury on angiotensin II-induced contraction in contral-
ateral carotid from type I-diabetic rat, as well as the inﬂuence of
the reactivity changes on blood ﬂow in this vessel. Since oxidative
stress induced by uncoupled nitric oxide synthases (NOS) is a
marker from type I-Diabetes (Szabó, 2009), we also investigated
the role of reactive oxygen species and NOS in these reactivity
changes.2. Materials and methods
All the experiments were carried out in accordance with the
Guide for the Care and Use of Laboratory Animals. A prior approval
was granted by the Animal Ethics Committee of the Faculty of
Medicine from Ribeirão Preto (FMRP) from the University of São
Paulo (USP) in Brazil (approval reference number: 007/2009). The
animals used in this study were kept under a 12 h light:12 h
darkness cycle (light from 06:00 to 18:00 h) and fed with regular
chow and water ad libitum.
2.1. Type I-Diabetes induction
8-weeks-old male Wistar rats (350–400 g) underwent to a
single intraperitoneal injection of streptozotocin (STZ, 55 mg/kg)
dissolved in citrate buffer (0.09 mol/l, pH 4.5) (day 0) (Pernomian
et al., 2012). A positive control group was composed by age-
matched normoglycaemic rats that underwent to citrate buffer
injection. Fasting glucose levels were determined from rat tail
blood samples prior to and 48 h (day 2) after STZ-injection, using a
one-touch glucometer (LifeScan Inc., Milpitas, CA, USA). Diabetic
rats presented a glycaemia higher than 300 mg/dl (Pernomian
et al., 2012) (Table 1).
2.2. Balloon catheter injury
Four weeks after STZ- or vehicle-injection (day 28) (Yousif
et al., 2006), balloon injury was performed in the left carotid
artery. Rats were anaesthetized with ketamine (50 mg/kg) and
xylazine (10 mg/kg), by intraperitoneal injection. The depth of the
anaesthesia was assessed by the loss of the motor reﬂexes and by
the immobility after pinching the rat tail tip. The left commoncarotid was exposed for access of a 2F Fogarty balloon catheter,
which was distended and passed three times through the carotid.
The catheter was removed, the external carotid was ligated and
the wound was closed. In anaesthetized sham operated rats, the
left common carotid was exposed and the external carotid artery was
ligated without performing catheterisation (Accorsi-Mendonça et al.,
2004; Pernomian et al., 2011).
To investigate if the compensatory response evoked by carotid
balloon injury is a sensory mechanism, some newborn rats (two-
day old) underwent to sensory chemodenervation by capsaicin
treatment (50 mg/kg, subcutaneous injection into the dorsal
region of the neck, under ice anaesthesia) (Newson et al., 2005)
before Diabetes induction.
2.3. Experimental groups
Fifteen days after balloon injury (Accorsi-Mendonça et al.,
2004), the fasting glucose was measured and the experiments
were performed. For the in vitro assays, the rats were sacriﬁced by
abdominal aortic exsanguination and the common carotid arteries
were isolated. The experimental groups used in all protocols
included: (1) the control carotid from normoglycaemic intact
(non-operated) rat; (2) the ipsi- (left) and (3) contralateral (right)
carotid arteries from normoglycaemic operated rat; (4) the control
carotid from diabetic intact rat; and (5) the ipsi- and (6) contral-
ateral carotid arteries from diabetic operated rat. Some protocols
also required a few more experimental groups. For instance, the
validation of STZ-induced Diabetes by measuring fasting glucose
levels required blood samples from citrate buffer-treated (intact)
rats. In turn, the validation of the consequences of balloon injury
on carotid responsiveness required the carotid from normogly-
caemic sham-operated rat in the in vitro arterial reactivity studies.
Furthermore, in order to assess the role of sensory nerves on the
functional consequences triggered by the neurocompensatory
response to carotid balloon injury, the following additional groups
were included in the functional assays (i.e., the in vitro arterial
reactivity studies and the in vivo carotid blood ﬂow and blood
pressure measurement): (1) the control carotid from capsaicin-
treated normoglycaemic intact rat; (2) the ipsi- and (3) contral-
ateral carotid arteries from capsaicin-treated normoglycaemic
operated rat; (4) the control carotid from capsaicin-treated dia-
betic intact rat; and (5) the ipsi- and (6) contralateral carotid
arteries from capsaicin-treated diabetic operated rat.
2.4. Histological analysis of carotid rings
Carotid arteries were ﬁxed in situ with formalin (10%) for 24 h,
and then embedded in parafﬁn. The 3 μm-cut sections of the
parafﬁn-included carotid rings were stained with hematoxylin and
eosin (HE) to morphological and morphometrical analysis, by using
an optic microscopy coupled to a digital camera (Coolpix 4500, Roper
Scientiﬁc, Japan). The images were edited in the Adobe Photoshop
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carotid layers thickness) was performed by using the Image J soft-
ware (1.33u version, NIH, USA) (de Andrade et al., 2006).
2.5. In vitro arterial reactivity studies
Common carotid arteries were removed and placed immedi-
ately in Krebs solution (composition in mmol/l: NaCl 118.4; KCl
4.7; CaCl2 1.9; KH2PO4 1.2; MgSO4 7H2O 1.2; NaHCO3 25; C6H12O6
11.6) at pH 7.4. Carotid rings (4 mm) were placed in 5.0 mL of
Krebs solution in organ bath chambers, gassed with 95% O2 and 5%
CO2 and maintained at 37 1C, pH 7.4. The rings were connected to
an isometric force transducer (Letica Scientiﬁc Instruments, Bar-
celona, Spain) to measure changes in the isometric tension. After
60 min of stabilization at a resting tension of 1 g, the viability
of the carotid rings was tested with the appropriated molar
concentration of phenylephrine that produces 50% of the max-
imum contraction response (EC50) in each experimental group
(EC50 Phenylephrine¼0.1 μmol/l for carotid arteries from normogly-
caemic rats, or EC50 Phenylephrine¼10 nmol/l for carotid arteries
from diabetic rats), as previously determined by cumulative
concentration-response curves for phenylephrine. The endothelial
integrity was veriﬁed with the appropriated molar concentration
of acetylcholine that produces 100% of the maximum relaxation
response (EC100) in each experimental group (EC100 Acetylcholi-
ne¼1.0 μmol/l for carotid arteries from normoglycaemic rats, or
EC100 Acetylcholine¼100 μmol/l for carotid arteries from diabetic
rats), over phenylephrine-induced pre-contraction. For studies
with endothelium-intact vessels, the ring was discarded if the
maximum relaxation induced by acetylcholine did not reach 80–
100%. When necessary, the endothelium was mechanically
removed by gentle rubbing the vessel in a thin wire. Endothelium
was deemed absent when the relaxation response to acetylcholine
did not occur (Pernomian et al., 2011, 2012).
Cumulative concentration-response curves for angiotensin II
(10−11–10−6 mol/l) were obtained in endothelium-intact or
endothelium-denuded carotid rings, in the absence or presence
of the selective O2− scavenger, 4,5-dihydroxy-1,3-benzenedisul-
phonic acid disodium salt monohydrate (tiron, 0.1 mmol/l)
(Pernomian et al., 2012), the selective H2O2 scavenger, polyethy-
lene glycol (PEG)-catalase (250 U/ml) (Pernomian et al., 2012), the
selective endothelial NOS (eNOS) inhibitor, N-nitro-L-arginine
(L-NNA, 100 μmol/l) (Dwyer et al., 1991), the selective neuronal
NOS (nNOS) inhibitor, Nϖ-propyl-L-arginine (L-NPA, 50 nmol/l)
(Ralevic, 2002) or the selective inducible NOS (iNOS) inhibitor,
N-[3-(aminomethyll)benzyl]acetaminide (1400 W, 10 nmol/l)
(Bonaventura et al., 2009), added 30 min prior angiotensin II.
In order to investigate if the compensatory response evoked by
carotid balloon injury is a bed-dependent mechanism, cumulative
concentration-response curves for angiotensin II (10−11–10−6 mol/
l) were obtained in endothelium-intact thoracic aorta rings
(4 mm) from normoglycaemic or diabetic intact or operated rats
(Accorsi-Mendonça et al., 2004).
At the end of the reactivity studies, the carotid and aorta rings
(4 mm) were dried in a dry incubator for 24 h. The arterial dry
mass (mg) was used to normalize the contractile response induced
by angiotensin II (Pernomian et al., 2012).
2.6. Reactive oxygen species measurements
2.6.1. O2
− measurement by confocal microscopy in carotid rings
Carotid rings (250 μm thickness) were placed vertically in a
coverslip covered with poly-L-lysine solution. The tissue was
loaded with the non-selective ﬂuorescent dye for reactive oxygen
species detection, dihydroethidium (DHE, 2.5 μmol/l, 30 min, at
37 1C), which was prepared in Hanks solution (composition inmmol/l: CaCl2 1.6; MgSO4 1.0; NaCl 145.0; KCl 5.0; NaH2PO4 0.5;
dextrose 10.0; HEPES 10.0) at pH 7.4 (Oliveira et al., 2009).
Reactive oxygen species level in the tissue was assessed by a
confocal laser microscope (Leica TSC SP5). DHE was excited in
488 nm line of an argon ion laser at 570 nm and the emitted
ﬂuorescence was measured at 650 nm. Time course software was
used to capture images of the tissues at 1.314 s intervals (xyt) in
the Live Data Mode acquisition (Oliveira et al., 2009).
Carotid rings were stimulated with angiotensin II (EC50) at
t¼100 s, in the absence or presence of tiron (0.1 mmol/l, 30 min)
or L-NNA (100 μmol/l, 30 min). As previously determined in
cumulative concentration-response curves, the angiotensin II
EC50 for carotid arteries from normoglycaemic rats was 1 nmol/l
and for carotid arteries from diabetic rats 30 nmol/l.
2.6.2. H2O2 measurement by ﬂow cytometry in carotid endothelial
cells
Carotid arteries were isolated and longitudinally sectioned.
Endothelial cells were mechanically isolated from the vessels via
gentle friction with a plastic stem in plates containing Hanks'
solution (composition in mmol/l: CaCl2 1.6; MgSO4 1.0; NaCl 145.0;
KCl 5.0; NaH2PO4 0.5; dextrose 10.0; HEPES 10.0) at pH 7.4, as
previously described by Pernomian et al. (2012). The cell suspen-
sions were centrifuged at 1.375hg for 5 min, and the pellets were
resuspended in 0.5 ml of Hanks' solution in a humidiﬁed incubator
at 37 1C until use (Bonaventura et al., 2008; Pernomian et al., 2011,
2012). Each n comprised a pool of six carotid arteries. The cell
viability was determined previously by trypan blue staining (2%)
and counting in a Neubauer chamber (Weber Scientiﬁc Interna-
tional, Germany).
The endothelial cells samples were loaded with the selective
ﬂuorescent dye for H2O2, 5(6)-carboxy-2′,7′-dichloroﬂuorescein
diacetate (CDCF-DA, 1 μmol/l, 20 min, 25 1C) (Du et al., 2006). A
cytoﬂuorographic analysis was performed using a Becton–Dick-
inson FACScan (San Jose, CA, USA) with an argon ion laser set at
488 nm with an output of 15 mW. The ﬁrst ﬂow cytometric
analysis of the cell suspension was performed in the absence of
CDCF-DA to verify the basal ﬂuorescence of blank samples.
The basal levels of H2O2 from endothelial cells was measured in
the absence or presence of PEG-catalase (3000 U/ml, 30 min)
(Robertson et al., 2009) or L-NPA (50 nmol/l, 30 min), added to
the cellular samples during CDCF-DA loading.
2.7. NOS expression assessment by immunohistochemistry
Ion parafﬁn-included carotid rings were cut into 3 μm sections
and mounted on poly-L-lysine-coated slides, which were rinsed
with phosphate-buffered saline (PBS) and immersed in 3% H2O2
for 20 min to block endogenous peroxidase. Non-speciﬁc protein
binding was blocked with normal serum for 30 min. The sections
were incubated with rabbit monoclonal primary antibody against
eNOS or nNOS (1:300) for 2 h at 25 1C. Following washes in PBS,
biotinylated pan-speciﬁc universal secondary antibody (1:300)
was applied for 30 min. The slides were incubated with avidin–
biotin peroxidase complex for 30 min. The slides were counter-
stained by haematoxylin, dehydrated and mounted with Per-
mount. As negative controls, all specimens were incubated with
an isotope-matched control antibody under identical conditions.
The immunolabeling was considered positive when distinct red
nuclear or cytoplasmic staining was homogenously present
(Pernomian et al., 2012).
2.8. Carotid blood ﬂow and blood pressure measurement
Rats were anaesthetized with ketamine (50 mg/kg) and xyla-
zine (10 mg/kg), by intraperitoneal injection. The left and right
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time ﬂow probe (model 1.5RB; Transonic Systems, Inc., Ithaca, NY,
USA) was placed around each carotid artery and connected to a
ﬂow meter (model T-206; Transonic system, USA). Basal mean
blood pressure was determined in anaesthetized rats after femoral
artery cannulation (Accorsi-Mendonça et al., 2004).2.9. Data analysis
Data were expressed as the mean7S.E.M., and the differences
between the mean values were assessed using the two-way
analysis of variance (ANOVA) followed by Bonferroni post-hoc test.
The signiﬁcance level considered in all of the tests was 0.05.
In the in vitro arterial reactivity studies, the concentration-
response curves were ﬁtted using a nonlinear interactive ﬁtting
programme (GraphPad Prism 5.00; GraphPad Software Inc., San
Diego, CA). The potencies and maximum responses to angiotensin
II were expressed as pD2 (negative logarithm of the molar
concentration of the agonist that produces 50% of the maximum
response) and Emax (maximum effect elicited by the agonist),
respectively. The pD2 and Emax values were obtained from the
non-linear regression of the angiotensin II-evoked contraction.
Emax was expressed as grams of isometric tension by milligrams of
dry tissue (g/mg).
In the confocal microscopy assays, the muscular ﬂuorescence
intensity (FI) was measured from DHE-loaded carotid rings. The
initial ﬂuorescence value at t¼0 s was taken as the basal ﬂuores-
cence (F0), and the ﬁnal ﬂuorescence intensity value (Ff) was
registered at t¼500 s, after angiotensin II addition.Fig. 1. Representative histological sections of carotid arteries from normoglycaemic or d
arteries from normoglycaemic rats, (D) Control, (E) Ipsi-, and (F) Contralateral carotid art
Adv (adventitia).In the ﬂow cytometry analysis, the median values of the
ﬂuorescence intensity (FI) emitted by blank or CDCF-DA-loaded
endothelial cells samples were determined using DIVA software
and expressed in ﬂuorescence units (U).
In the immunohistochemical assays, the percentage of the
stained area was determined by Image J, in which it was delimited
an area of 45 μm2 for the endothelium, 900 μm2 for the media or
for the adventitia from carotid sections.
In the in vivo experiments, the mean carotid blood ﬂow (F) was
recorded by 10 min in a computational acquisition system (Dataq,
USA), which provided an actual volume ﬂow measurement in a
resolution of 0.05 ml/min. Mean blood pressure (BP) baseline
values were calculated as the average of the 10 min recording,
by using the acquisition system Dataq (USA). F and BP were used
to calculate the peripheral vascular resistance (PVR) by applying
the formulae PVR¼BP/F.2.10. Drugs, chemical reagents and other materials
STZ, capsaicin, (ASN1,VAL5)-angiotensin II acetate, Tiron, PEG-
catalase, L-NNA, 1400W, CDCF-DA (Sigma, St. Louis, MO, USA);
ketamine (União Química, Jabaquara, SP, Brazil); xylazine (Calier
Laboratory, Jubatuba, MG, Brazil); L-NPA (Tocris, Avonmouth, UK);
KCl, CaCl2 and other salts (Synth, São Paulo, SP, Brazil); DHE
(Invitrogen, Carlsbad, CA, USA); anti-eNOS, anti-nNOS (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA); biotinylated universal
secondary antibody, avidin–biotin peroxidase complex (Vectastain
Elite ABC kit, Universal, Vector Laboratories Inc. U.S. Headquarters,
Burlingame, CA, USA). STZ was dissolved in citrate buffer
(0.09 mol L−1, pH 4.5). DHE and CDCF-DA were prepared as stockiabetic (intact or operated) rats: (A) Control, (B) Ipsi-, and (C) Contralateral carotid
eries from diabetic rats. HE (magniﬁcation: 100 ). E (endothelium), M (media) and
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as stock solutions in 10% Tween 80 and 10% ethanol. The other
drugs were dissolved in distilled water. The concentration of
DMSO or 10% Tween 80 and 10% ethanol in the solutions used in
the experiments did not exceed 0.05% and had no in vitro or in vivo
effects.3. Results
3.1. Histological analysis of carotid rings
Morphological analysis showed that, in normoglycaemic or
diabetic rats, balloon catheter injury induced neointima formation
in their ipsilateral carotid arteries, but did not alter the wall
structure of their contralateral carotid arteries (Fig. 1B, C, E and
F). Morphometrical analysis showed that type I-Diabetes reduced
the media thickness of control (29.3971.86 μm, n¼5), ipsi-
(26.1872.56 μm, n¼5) and contralateral (28.5671.97 μm, n¼5)
carotid arteries when compared to control (53.2974.83 μM, n¼5),
ipsi-(45.2674.68 μm, n¼5) and contralateral (51.2474.91 μm,
n¼5) carotid arteries from normoglycaemic rats, respectively
(Fig. 1A–F). This remodelling reduced the dry mass of control
(0.3970.009 mg, n¼5), ipsi-(0.4170.007 mg, n¼5) and contral-
ateral (0.3870.014 mg, n¼5) carotid arteries from diabetic rats
when compared to control (0.5070.008 mg, n¼5), ipsi-
(0.4970.004 mg, n¼5) and contralateral (0.5270.009 mg, n¼5)
carotid arteries from normoglycaemic rats, respectively.Fig. 2. Angiotensin II-induced contraction in endothelium-intact (Eþ) or endothe-
lium-denuded (E−) control, ipsi- or contralateral carotid arteries from normogly-
caemic or diabetic (intact or operated) rats: (A) Angiotensin II concentration-
response curves in carotid arteries from normoglycaemic rats, (B) Angiotensin II
concentration-response curves in carotid arteries from diabetic rats, and (C) Emax
values for Angiotensin II in carotid arteries from normoglycaemic or diabetic rats.
Signiﬁcant difference (Po0.05; n¼7) compared to Eþ control carotid arteries from
normoglycaemic (*) or diabetic (♯) (intact) rats, Eþ contralateral carotid arteries
from diabetic (operated) rats (§), to E− control carotid arteries from normoglycae-
mic (**) or diabetic (♯♯) (intact) rats, or to E− contralateral carotid arteries from
normoglycaemic (operated) rats (††).3.2. In vitro arterial reactivity studies
3.2.1. Consequences of carotid balloon injury on angiotensin
II-induced contraction in contralateral carotid from diabetic rat
Considering our ﬁndings that show the media remodelling
induced by type I-Diabetes in carotid arteries, the contractile
responses evoked by angiotensin II were normalized by the
arterial dry mass (mg).
The contraction induced by angiotensin II in endothelium-
intact carotid arteries of normoglycaemic sham-operated rats
(Emax¼0.5170.03 g/mg, pD2¼9.0270.16, n¼7) was not different
from that one observed in endothelium-intact control carotid
arteries of normoglycaemic intact rats (Emax¼0.5670.04 g/mg,
pD2¼8.9970.16, n¼7). Thus, normoglycaemic intact rats were
used as the control group to avoid unnecessary animal suffering. In
capsaicin-treated normoglycaemic intact rats, the contraction
evoked by angiotensin II in endothelium-intact control carotid
arteries (Emax¼0.5470.04 g/mg, pD2¼8.8770.23, n¼7) was not
different from that one observed in endothelium-intact control
carotid arteries of no treated normoglycaemic intact rats. Endothe-
lium removal increased the angiotensin II Emax value in control
carotid arteries from normoglycaemic intact rats, without chan-
ging the pD2 value (8.5970.18, n¼7) (Fig. 2A and C).
In normoglycaemic rats, balloon catheter injury reduced the
angiotensin II Emax value in ipsilateral carotid (Emax¼0.3370.03 g/
mg, n¼7), without changing the pD2 value (pD2¼8.7270.33,
n¼7) (Fig. 2A). In endothelium-intact contralateral carotid arteries
from normoglycaemic operated rats, the angiotensin II Emax value
was increased, without changes in the pD2 value (pD2¼
9.0470.192, n¼7) (Fig. 2A and C). In capsaicin-treated normogly-
caemic operated rats, the contraction evoked by angiotensin II in
ipsilateral carotid arteries (Emax¼0.2870.02 g/mg, pD2¼9.117
0.31, n¼7) was not different from that one observed in the
ipsilateral carotid arteries from no treated normoglycaemic oper-
ated rats. However, capsaicin treatment restored the angiotensin II
Emax value in endothelium-intact contralateral carotid arteriesfrom normoglycaemic operated rats (Emax¼0.52 70.03 g/mg,
n¼7), without changing the pD2 value (pD2¼8.8570.33, n¼7).
Endothelium removal did not alter the contraction induced by
Fig. 3. Effect of reactive oxygen species scavengers on the angiotensin II-induced contraction in endothelium-intact control or contralateral carotid arteries from
normoglycaemic or diabetic (intact or operated) rats: (A) Angiotensin II concentration-response curves in carotid arteries from normoglycaemic rats, (B) Angiotensin II
concentration-response curves in carotid arteries from diabetic rats, and (C) Emax values for Angiotensin II in carotid arteries from normoglycaemic or diabetic rats. Signiﬁcant
difference (Po0.05; n¼7) compared to control carotid arteries from normoglycaemic (intact) rats in the absence (no pre-treated) (*) or presence of tiron (**) or PEG-catalase
(***), to contralateral carotid arteries from normoglycaemic (operated) rats in the absence (†) or presence of tiron (††) or PEG-catalase (†††), to control carotid arteries from
diabetic (intact) rats in the absence (♯) or presence of tiron (♯♯) or PEG-catalase (♯♯♯), or to contralateral carotid arteries from diabetic (operated) rats in the absence (§) or
presence of tiron (§§).
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operated rats (pD2¼8.5670.08, n¼7) when compared to the pre-
sence of endothelium (Fig. 2A and C).
Type I-Diabetes increased the angiotensin II Emax value in
endothelium-intact rat carotid, but reduced the pD2 value (7.677
0.259, n¼7) (Fig. 2B and C). In capsaicin-treated diabetic intact
rats, the contraction evoked by angiotensin II in endothelium-
intact carotid arteries (Emax¼1.6170.08 g/mg, pD2¼7.5170.48,
n¼7) was not different from that one observed in endothelium-
intact carotid arteries of no treated diabetic intact rats. Endothe-
lium removal reduced the angiotensin II Emax value and restored
the pD2 value in control carotid arteries from diabetic intact rats
(8.5970.34, n¼7) (Fig. 2B and C).
In ipsilateral carotid arteries from diabetic rats, balloon
catheter injury reduced the angiotensin II Emax value
(0.2970.031 g/mg, n¼7) to the level of the value observed in
the ipsilateral carotid arteries from normoglycaemic operated
rats, but did not alter the pD2 value (7.5870.09, n¼7) when
compared to endothelium-intact control carotid arteries from
diabetic intact rats (Fig. 2B). When compared to endothelium-
intact control carotid arteries of diabetic intact rats, theangiotensin II Emax value in endothelium-intact contralateral
carotid arteries from diabetic operated rats was reduced, with-
out changes in the pD2 value (7.5270.093, n¼7) (Fig. 2B and C).
The angiotensin II Emax value in endothelium-intact contralat-
eral carotid arteries from diabetic operated rats remained higher
than that one observed in endothelium-intact control carotid
arteries from normoglycaemic intact rats, but close to the value
observed in endothelium-intact contralateral carotid arteries
from normoglycaemic operated rats (Fig. 2A–C). In capsaicin-
treated diabetic operated rats, the contraction evoked by angio-
tensin II in ipsilateral carotid arteries (Emax¼0.3170.01 g/mg,
pD2¼7.4270.49, n¼7) was not different from that one
observed in the ipsilateral carotid arteries from no treated
diabetic operated rats. Capsaicin treatment increased the angio-
tensin II Emax value in contralateral carotid arteries from diabetic
operated rats (1.5970.09 g/mg, n¼7) to the level of the value
observed in control carotid arteries from diabetic intact rats, and
restored the pD2 value (9.1570.351, n¼7). Also, endothelium
removal increased the angiotensin II Emax and restored the pD2
value (8.6370.078, n¼7) in contralateral carotid arteries from
diabetic operated rat (Fig. 2A–C).
Fig. 4. Effect of NOS inhibitors on the angiotensin II-induced contraction in endothelium-intact control or contralateral carotid arteries from normoglycaemic or diabetic (intact or
operated) rats: (A) Angiotensin II concentration-response curves in carotid arteries from normoglycaemic rats, (B) Angiotensin II concentration-response curves in carotid arteries
from diabetic rats, and (C) Emax values for Angiotensin II in carotid arteries from normoglycaemic or diabetic rats. Signiﬁcant difference (Po0.05; n¼7) compared to control carotid
arteries from normoglycaemic (intact) rats in the absence (no pre-treated) (*) or presence of L-NNA (**), L-NPA (***) or 1400W (****), to contralateral carotid arteries from
normoglycaemic (operated) rats in the absence (†) or presence of L-NNA (††) or L-NPA (†††), to control carotid arteries from diabetic (intact) rats in the absence (♯) or presence of L-NNA
(♯♯) or 1400W (♯♯♯♯), or to contralateral carotid arteries from diabetic (operated) rats in the absence (§) or presence of L-NNA (§§) or L-NPA (§§§).
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II-induced contraction in contralateral carotid from diabetic rat
Tiron did not alter the maximum contraction evoked by
angiotensin II in endothelium-intact control carotid arteries from
normoglycaemic intact rats, but reduced the angiotensin II Emax
value in endothelium-intact control carotid arteries from diabetic
intact rats at the same extent as endothelium removal. Also, tiron
restored the angiotensin II Emax value in both endothelium-intact
contralateral carotid arteries form normoglycaemic and diabetic
operated rats (Fig. 3A–C). The angiotensin II pD2 values in
endothelium-intact control carotid arteries from normoglycaemic
(9.0470.13, n¼7) or diabetic (7.6870.12, n¼7) intact rats, as well
as in endothelium-intact contralateral carotid arteries from nor-
moglycaemic (8.8170.21, n¼7) or diabetic (7.6370.17, n¼7)
operated rats, were not altered by tiron when compared to the
absence of the O2− scavenger (Fig. 3A and B).
PEG-catalase reduced the angiotensin II Emax value in
endothelium-intact control carotid arteries of normoglycaemic or
diabetic intact rats, but increased this value in endothelium-intact
contralateral carotid arteries from normoglycaemic or diabetic
operated rats (Fig. 3A–C). The angiotensin II Emax value in
endothelium-intact contralateral carotid arteries from diabetic
operated rats was similar to that one observed in this vessel afterendothelium removal or in no pre-treated endothelium-intact
control carotid arteries from diabetic intact rats (Fig. 3B and C).
PEG-catalase did not alter the angiotensin II pD2 values in
endothelium-intact control carotid arteries from normoglycaemic
(8.3070.26, n¼7) or diabetic (7.6970.11, n¼7) intact rats, as well
as in endothelium-intact contralateral carotid arteries from nor-
moglycaemic operated rats (8.7470.17, n¼7), but restored this
value in endothelium-intact contralateral carotid arteries from
diabetic operated rats (8.9170.03, n¼7) at the same extent as
endothelium removal (Fig. 3A and B).3.2.3. Modulation played by NOS metabolites on angiotensin
II-induced contraction in contralateral carotid from diabetic rat
L-NNA increased the angiotensin II Emax value in endothelium-
intact control carotid arteries from normoglycaemic intact rats at
the same extent as endothelium removal, without changing the
pD2 value (8.3770.17, n¼7) (Fig. 4A and C). In endothelium-intact
control carotid arteries from diabetic intact rats, L-NNA did not
alter the contraction induced by angiotensin II (pD2¼7.5470.13,
n¼7) when compared to the absence of the NOS inhibitor (Fig. 4B
and C). As tiron, L-NNA restored the angiotensin II Emax values in
both endothelium-intact contralateral carotid arteries from
Fig. 5. Representative images of the FI time-course emitted by DHE-loaded control or contralateral carotid rings from normoglycaemic or diabetic (intact or operated) rats,
before (t¼0 s) and after (t¼100 s) angiotensin II addition (n¼5): (A) control carotid rings from normoglycaemic (intact) rats, (B) contralateral carotid rings from
normoglycaemic (operated) rats, (C) control carotid rings from diabetic (intact) rats, and (D) contralateral carotid rings from diabetic (operated) rats.
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pD2 values (9.4370.36 and 7.7070.17, n¼7, respectively)
(Fig. 4A–C).
L-NPA did not alter the contraction induced by angiotensin II in
endothelium-intact control carotid arteries from normoglycaemic
(pD2¼9.3970.20 n¼7) or diabetic (pD2¼7.5370.18, n¼7) intact
rats, but increased the angiotensin II Emax value in both
endothelium-intact contralateral carotid arteries from normogly-
caemic or diabetic operated rats, at the same extent as PEG-
catalase (Fig. 4A–C). In endothelium-intact contralateral carotid
arteries from diabetic operated rats, L-NPA restored the pD2 value
(8.6970.24, n¼7) as PEG-catalase or endothelium removal
(Fig. 4B).
1400W did not alter the contraction induced by angiotensin II
neither in control nor in contralateral carotid arteries from
normoglycaemic or diabetic rats (Fig. 4A–C).3.2.4. Consequences of carotid balloon injury on angiotensin
II-induced contraction in aorta from diabetic rat
The contraction induced by angiotensin II in endothelium-
intact aorta arteries of normoglycaemic operated rats (Emax¼
1.7570.162 g/mg, pD2¼8.8870.19, n¼7) was not different from
that one observed in endothelium-intact aorta arteries of normo-
glycaemic intact rats (Emax¼1.8370.15 g/mg, pD2¼9.0670.24,n¼7). Type I Diabetes increased the angiotensin II Emax value in
endothelium-intact rat aorta (3.0270.20 g/mg, n¼7), without
changing the pD2 value (9.0570.21, n¼7). The contraction
induced by angiotensin II in endothelium-intact aorta arteries
from diabetic operated rats (Emax¼2.9370.19 g/mg, pD2¼8.937
0.21, n¼7) was not different from that one observed in
endothelium-intact aorta arteries from diabetic intact rats.
3.3. Reactive oxygen species measurements
3.3.1. Consequences of carotid balloon injury on O2
− levels
in contralateral carotid from diabetic rat
In control carotid arteries from normoglycaemic intact rats,
angiotensin II did not alter the basal FI emitted by the endothelium
(F0¼57.2873.95 U; Ff¼55.3873.92 U, n¼5), media or adventitia
layers (Figs. 5A, 6A, B, and 7A, B). Although the basal endothelial
(F0¼51.7374.68 U, n¼5) and adventitial FI in DHE-loaded con-
tralateral carotid rings from normoglycaemic operated rats had not
been altered when compared to control carotid rings from nor-
moglycaemic intact rats (Endothelial F0¼57.2873.95 U, n¼5), the
basal muscular FI emitted by these rings was increased (Figs. 5B
and 6A, B). Angiotensin II increased the muscular FI in contral-
ateral carotid rings from normoglycaemic operated rats, while
tiron or L-NNA reduced the basal and angiotensin II-induced
muscular FI emitted by these rings at a same extent (Fig. 6A and B).
Fig. 6. Effect of tiron or L-NNA on the basal and angiotensin II-induced muscular FI
emitted by DHE-loaded control or contralateral carotid rings from normoglycaemic
or diabetic (intact or operated) rats: (A) effect of tiron on FI emitted by DHE-loaded
carotid rings, and (B) effect of L-NNA on FI emitted by DHE-loaded carotid rings.
Signiﬁcant difference (Po0.05; n¼5) compared to no pre-treated control carotid
rings from normoglycaemic (intact) rats before (*) or after angiotensin II addition
(**), to L-NNA-pre-treated control carotid rings from normoglycaemic (intact) rats
before (***) or after angiotensin II addition (****), to no pre-treated contralateral
carotid rings from normoglycaemic (operated) rats before (†) or after angiotensin II
addition (††), to no pre-treated control carotid rings from diabetic (intact) rats
before (♯) or after angiotensin II addition (♯♯), to L-NNA-pre-treated control carotid
rings from diabetic (intact) rats before (♯♯♯) or after angiotensin II addition (♯♯♯♯), to
no pre-treated contralateral carotid rings from diabetic (operated) rats before (§) or
after (§§) angiotensin II addition.
Fig. 7. Effect of tiron or L-NNA on the basal and angiotensin II-induced adventitial
FI emitted by DHE-loaded control or contralateral carotid rings from normogly-
caemic or diabetic (intact or operated) rats: (A) effect of tiron on FI emitted by DHE-
loaded carotid rings, and (B) effect of L-NNA on FI emitted by DHE-loaded carotid
rings. Signiﬁcant difference (Po0.05; n¼5) compared to no pre-treated control
carotid rings from normoglycaemic (intact) rats before (*) or after angiotensin II
addition (**), to L-NNA-pre-treated control carotid rings from normoglycaemic
(intact) rats before (***) or after angiotensin II addition (****), to no pre-treated
contralateral carotid rings from normoglycaemic (operated) rats before (†) or after
angiotensin II addition (††), to no pre-treated control carotid rings from diabetic
(intact) rats before (♯) or after angiotensin II addition (♯♯), to L-NNA-pre-treated
control carotid rings from diabetic (intact) rats before (♯♯♯) or after angiotensin II
addition (♯♯♯♯), to no pre-treated contralateral carotid rings from diabetic (operated)
rats before (§) or after (§§) angiotensin II addition.
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the basal endothelial FI (F0¼112.9876.40 U, n¼5) was increased,
while the basal muscular or adventitial FI were not altered when
compared to control carotid rings from normoglycaemic intact rats
(Figs. 5C, 6A, B, and 7A, B). Angiotensin II increased the endothelial
FI in control carotid rings from diabetic intact rats (Ff¼
188.9678.30 U, n¼5) (Fig. 5C). In these rings, tiron reduced the
basal and angiotensin II-induced endothelial FI (F0¼14.667
1.43 U; Ff¼17.0971.58 U, n¼5) at a same extent, while L-NNA
did not alter these values (F0¼119.0379.81 U; Ff¼197.457
10.07 U, n¼5).
The basal endothelial FI in DHE-loaded contralateral carotid
rings from diabetic operated rats (F0¼49.7175.07 U, n¼5) was
not altered when compared to control carotid rings from normo-
glycaemic intact rats (Fig. 5D). However, the basal muscular andadventitial FI emitted by these rings was increased (Figs. 5B, 6A, B,
and 7A, B). Also, angiotensin II increased the muscular and
adventitial FI emitted by contralateral carotid rings from diabetic
operated rats, while tiron or L-NNA reduced the basal and
angiotensin II-induced muscular and adventitial FI in these rings
at a same extent (Figs. 5D, 6A, B, and 7A, B).3.3.2. Consequences of carotid balloon injury on endothelial H2O2
levels in contralateral carotid from diabetic rat
The basal FI emitted by CDCF-DA-loaded endothelial cells from
control carotid arteries of diabetic intact rats, as well as from
contralateral carotid arteries from normoglycaemic or diabetic
operated rats, was increased (Fig. 8F–I). This basal FI increase
Fig. 8. Basal H2O2 levels in endothelial cells from control or contralateral carotid arteries of normoglycaemic or diabetic (intact or operated) rats. The representative dot plots
show the gates of endothelial cells from (A) control carotid arteries of normoglycaemic (intact) rats, (B) contralateral carotid arteries of normoglycaemic (operated) rats,
(C) control carotid arteries of diabetic (intact) rats and (D) contralateral carotid arteries of diabetic (operated) rats. The representative histograms show the basal ﬂuorescence
emitted by CDCF-DA-loaded endothelial cells samples from (E) control carotid arteries of normoglycaemic (intact) rats, (F) contralateral carotid arteries of normoglycaemic
(operated) rats, (G) control carotid arteries of diabetic (intact) rats and (H) contralateral carotid arteries of diabetic (operated) rats. (I) Quantiﬁcation of the basal ﬂuorescence
emitted by blank or CDCF-DA-loaded endothelial samples, in the absence or presence of PEG-catalase or L-NPA. Signiﬁcant difference (Po0.05; n¼5) compared to the
respective blank samples (γ), to no pre-treated (*), PEG-catalase- (**) or L-NPA- (***) pre-treated CDCF-DA-loaded endothelial cells from control carotid arteries of
normoglycaemic (intact) rats, to no pre-treated contralateral carotid arteries of normoglycaemic (operated) rats (†), to no pre-treated (♯), PEG-catalase- (♯♯) or L-NPA- (♯♯♯) pre-
treated control carotid arteries of diabetic (intact) rats, or to no pre-treated contralateral carotid arteries of diabetic (operated) rats (§).
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Fig. 9. eNOS expression in control or contralateral carotid arteries from normoglycaemic or diabetic (intact or operated) rats: (A) eNOS staining in control carotid arteries
from normoglycaemic (intact) rats, (B) eNOS staining in contralateral carotid arteries from normoglycaemic (operated) rats, (C) eNOS staining in control carotid arteries from
diabetic (intact) rats, (D) eNOS staining in contralateral carotid arteries from diabetic (operated) rats, and (E) quantiﬁcation of eNOS expression in carotid layers. The staining
is denoted in red by the arrows (magniﬁcation: 100 ). E (endothelium), M (media) and Adv (adventitia). Signiﬁcant difference (Po0.05; n¼5) compared to the respective
layer of control carotid arteries from normoglycaemic (intact) rats (*), contralateral carotid arteries from normoglycaemic (operated) rats (†) or control carotid arteries from
diabetic (intact) rats (♯). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 10. nNOS expression in control or contralateral carotid arteries from normoglycaemic or diabetic (intact or operated) rats: (A) nNOS staining in control carotid arteries
from normoglycaemic (intact) rats, (B) nNOS staining in contralateral carotid arteries from normoglycaemic (operated) rats, (C) nNOS staining in control carotid arteries from
diabetic (intact) rats, (D) nNOS staining in contralateral carotid arteries from diabetic (operated) rats, and (E) quantiﬁcation of nNOS expression in carotid layers. The staining
is denoted in red by the arrows (magniﬁcation: 100 ). E (endothelium), M (media) and Adv (adventitia). Signiﬁcant difference (Po0.05; n¼5) compared to the respective
layer of control carotid arteries from normoglycaemic (intact) rats (*), contralateral carotid arteries from normoglycaemic (operated) rats (†) or control carotid arteries from
diabetic (intact) rats (♯). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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carotid arteries of diabetic operated rats (Fig. 8H and I). PEG-
catalase reduced the basal FI emitted by CDCF-DA-loaded endothe-
lial cells from control or contralateral carotid arteries of normo-
glycaemic or diabetic (intact or operated) rats (Fig. 8I). Although L-
NPA had not altered the basal FI emitted by CDCF-DA-loaded
endothelial cells from control carotid arteries of normoglycaemic
or diabetic intact rats, the nNOS inhibitor reduced the basal FI at
the same extent as PEG-catalase in CDCF-DA-loaded endothelial
cells from contralateral carotid arteries of normoglycaemic or
diabetic operated rats (Fig. 8I).
3.4. NOS expression assessment
3.4.1. Consequences of carotid balloon injury on eNOS expression
in contralateral carotid from diabetic rat
In contralateral carotid arteries from normoglycaemic operated
rats, eNOS staining was reduced in the endothelium and adventi-
tia, but increased in the media layer (Fig. 9B and E). eNOS staining
was reduced in the endothelium, media and adventitia layers from
carotid arteries of diabetic intact rats (Fig. 9C and E). In contral-
ateral carotid arteries from diabetic operated rats, eNOS staining
was reduced in the endothelium but increased in the media and
adventitia layers when compared to control carotid arteries from
normoglycaemic intact rats (Fig. 9A, D and E).
3.4.2. Consequences of carotid balloon injury on nNOS expression
in contralateral carotid from diabetic rat
Muscular and adventitial nNOS staining was increased in
contralateral carotid arteries from normoglycaemic operated rats,
but reduced in control carotid arteries from diabetic intact rats
(Fig. 10B, C and E). In contralateral carotid arteries from diabetic
operated rats, nNOS staining was increased in the endothelium,
but reduced in the media and adventitia layers (Fig. 10D and E).
3.5. Consequences of carotid balloon injury on blood ﬂow
and resistance of contralateral carotid from diabetic rat
In ipsilateral carotid arteries from normoglycaemic or diabetic
operated rats, as well as in control carotid arteries from diabetic
intact rats, the basal blood ﬂow was reduced and the basal
resistance was increased (Fig. 11A and C). When compared to
control carotid arteries from diabetic intact rats, the basal blood
ﬂow and resistance of contralateral carotid arteries from diabetic
operated rats were restored (Fig. 11A and C). Capsaicin treatment
increased the blood ﬂow and reduced the resistance of control
(F¼7.2570.53 ml/min, PVR¼8.7973.66 U, n¼5) or contralateral
(F¼8.0170.49 ml/min, PVR¼9.2174.18 U, n¼5) carotid arteries
from normoglycaemic rats, but did not affect these parameters in
control carotid arteries from diabetic intact rats (F¼2.887
0.31 ml/min, PVR¼31.0773.24 U, n¼5). In diabetic operated rats,
capsaicin treatment reduced the blood ﬂow (3.0670.27 ml/min,
n¼5) and increased the resistance (36.1972.91 U, n¼5) of con-
tralateral carotid arteries to the levels observed in control carotid
arteries from diabetic intact rats.Fig. 11. Basal blood ﬂow, blood pressure and resistance in control, ipsilateral or
contralateral carotid arteries from normoglycaemic or diabetic (intact or operated)
anaesthetized rats: (A) basal blood ﬂow, (B) basal blood pressure, and (C) basal
peripheral resistance. Signiﬁcant difference (Po0.05; n¼7) compared to control
carotid arteries from normoglycaemic (*) or diabetic (♯) (intact) rats, or to ipsilateral
carotid arteries from normoglycaemic (†) or diabetic (§) (operated) rats.4. Discussion
In the present study, we hypothesized that type I-Diabetes
would abrogate the sensory neurocompensatory response elicited
by rat carotid balloon injury, and thus, it would promote an
increase in the contraction evoked by angiotensin II in the
contralateral carotid that could be enough to impair the local
blood ﬂow. Therefore, the impaired blood ﬂow in contralateral
carotid from diabetic rat, added to the reduced blood ﬂow in therestenotic ipsilateral carotid, could lead to further damage in the
carotid cerebral irrigation after angioplasty during type I-Diabetes.
However, our major new ﬁndings surprisingly showed that the
sensory neurocompensatory response to carotid balloon injury is
preserved during type I-Diabetes, since the diabetic hyperreactiv-
ity to angiotensin II in the contralateral carotid from diabetic rat
was attenuated by a capsaicin sensitive-sensory nerves-dependent
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nNOS-derived H2O2. At the same time, the blood ﬂow in contral-
ateral carotid from diabetic rat, previously impaired by Diabetes in
intact (non-operated) rats, was also restored by a capsaicin
sensitive-sensory nerves-dependent mechanism, while the blood
ﬂow in the restenotic ipsilateral carotid from diabetic rat remained
impaired. Thus, these ﬁndings, originally described in the present
study, point a vasoprotective pathophysiological signiﬁcance to the
sensory neurocompensatory response triggered by carotid balloon
injury during type I-Diabetes. This adaptive phenomenon may
have important implications in preventing further damage in the
cerebral irrigation by carotid pathways after angioplasty in type
I-diabetic subjects.
According to our data, type I-Diabetes in intact rats triggered a
contractile hyperreactivity to angiotensin II in carotid artery,
which is mediated by endothelium-derived O2− and H2O2, in
agreement with the ﬁndings described by Pernomian et al.
(2012). Interestingly, this effect was followed by an impairment
of the blood ﬂow in carotid artery from diabetic intact rat,
suggesting that the contractile hyperreactivity to angiotensin II
seems to contribute to the increased resistance of this vessel. In
addition, our ﬁndings showed that capsaicin treatment did not
alter the contractile response to angiotensin II or the basal blood
ﬂow in the carotid artery from type I-diabetic intact rat. Also, type
I-Diabetes sub-regulated the carotid expression of muscular and
adventitial nNOS, which is a normal component of sensory
perivascular nerves that reaches the media and adventitia layers
(Faraci, 2002; Si and Lee, 2002; McCuskey, 2004). Thus, these
ﬁndings suggest the occurrence of sensory perivascular neurode-
generation in carotid artery from type I-diabetic intact rat, as
previously described for other vessels in diabetic conditions
(Cellek et al., 2005; Sima, 2006).
Taken together, the ﬁndings described for diabetic rat carotid
seemed to support our original hypothesis that type I-Diabetes
would abrogate the sensory neurocompensatory response to
carotid balloon injury. Our ﬁndings showed that this compensa-
tion is a vascular bed-dependent mechanism that is not mediated
by humoral factors, since the angiotensin II-induced contractile
tone in aorta from rats that underwent carotid balloon injury is
not affected, in agreement with Accorsi-Mendonça et al. (2004).
The compensatory response to carotid balloon injury increases the
contraction induced by angiotensin II in contralateral carotid from
normoglycaemic rat (Accorsi-Mendonça et al., 2004), but this
hyperreactivity is lesser than that one triggered by type
I-Diabetes in carotid from intact rat (Pernomian et al., 2012).
Indeed, we showed that the contraction evoked by angiotensin II
in contralateral carotid from normoglycaemic operated rat is
increased in a lesser extent than in carotid artery from type
I-diabetic intact rat, by a capsaicin-sensitive sensory nerves-
mediated mechanism that involves the contractile effect from
muscular eNOS-derived O2−. Thus, we expected that the abroga-
tion of the sensory neurocompensatory response to balloon injury
would keep the diabetic hyperreactivity to angiotensin II in
contralateral carotid, which could be enough to impair the local
blood ﬂow.
Surprisingly, our ﬁndings showed that the bed-dependent
sensory neurocompensatory response to carotid balloon injury is
preserved in type I-diabetic rats, since a capsaicin-sensitive
sensory nerves-dependent mechanism attenuated the diabetic
hyperreactivity to angiotensin II in their contralateral carotid and
maintained the contraction induced by angiotensin II in this vessel
higher than the normoglycaemic control levels, without affecting
the angiotensin II-induced contractile tone in their aorta. The
residual hyperreactivity to angiotensin II in the contralateral
carotid from diabetic operated rat compensates the hyporespon-
siveness to angiotensin II in its restenotic ipsilateral carotid, whilethe sensory nerves-dependent attenuation of the diabetic hyper-
reactivity to angiotensin II in contralateral artery contributes
to restore the local blood ﬂow, previously impaired by type
I-Diabetes in intact rats.
According to our ﬁndings, the sensory neurocompensatory
response to carotid balloon injury in diabetic rats involves differ-
ent vascular effects mediated by O2− and H2O2. The residual
hyperreactivity to angiotensin II in contralateral carotid from
diabetic operated rat is mediated by O2− derived from adventitial
and muscular eNOS, which is overexpressed in the media and
adventitial layers from this vessel. In turn, the attenuation of the
diabetic hyperreactivity to angiotensin II in this vessel is mediated
by H2O2 derived from endothelial nNOS, which is overexpressed in
the endothelium from this vessel. Moreover, endothelial nNOS-
derived H2O2 also impairs the potency of angiotensin II in this
vessel. Indeed, O2− can be generated by uncoupled eNOS (Szabó,
2009), whose gene expression is sustained by capsaicin-sensitive
sensory nerves (Zvara et al., 2006). In addition, O2− induces a
contractile tone by intrinsic mechanisms, such as closing ATP
sensitive potassium channels or calcium activated potassium
channels (Liu and Gutterman, 2002), or activating extracellular
signaling-regulated kinase 1/2 (Ding et al., 2007), ryanodine
receptors (Du et al., 2005) or Rho-kinase (Pernomian et al., 2012;
Jin et al., 2004, 2006). On the other hand, milimolar concentrations
of H2O2 induce vasorelaxation (Gao et al., 2003), and vascular
nNOS can generate H2O2 (Capettini et al., 2010).
Our ﬁndings also showed that the modulation played by
different reactive oxygen species on angiotensin II-induced tone
in contralateral carotid from diabetic rat is similar to that one
evoked on contralateral carotid from normoglycaemic rat, in which
eNOS-derived O2− also plays as a contractile factor and nNOS-
derived H2O2 as a relaxant one. However, in diabetic rats, the
nNOS-mediated pathway is an endothelium-dependent mechan-
ism, while in normoglycaemic rats this mechanism depends on
muscular and/or adventitia layers. This corroborates with the data
showing that type I-Diabetes impairs the carotid muscular and
adventitial expression of nNOS, which was after overexpressed in
the endothelium from diabetic rat contralateral carotid by the
compensatory response to balloon injury. As nNOS is a normal
component of nitrergic sensory perivascular nerves that reaches
the media and adventitia layers (Faraci, 2002; Si and Lee, 2002;
McCuskey, 2004), we can suggest that the sensory neurocompen-
satory response to carotid balloon injury in diabetic rats has
attenuated the diabetic loss of nitrergic sensory perivascular
innervation by overexpressing the endothelial nNOS in the con-
tralateral artery. Also, since our ﬁndings show that the neurocom-
pensatory response to carotid balloon injury in diabetic rats
depends on a sensory mechanism, we can suggest a positive
correlation between sensory nerves and the endothelial nNOS
expression. Indeed, Prado et al. (2008) had already demonstrated
that the acute stimulation of sensory nerve ﬁbres or the infusion of
SP increases the expression of nNOS in respiratory endothelial cells
from guinea-pigs.5. Conclusions
In summary, our ﬁndings showed that carotid balloon injury in
type I-diabetic rats elicits a bed-dependent sensory neurocom-
pensatory response mediated by a capsaicin-sensitive sensory
nerves-dependent mechanism that involves different vascular
effects played by O2− and H2O2. While O2− derived from adventi-
tial and muscular eNOS triggers a contractile tone that keeps a
residual hyperreactivity to angiotensin II in contralateral carotid
from diabetic operated rat, H2O2 derived from endothelial nNOS
attenuates the diabetic hyperreactivity to angiotensin II in this
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ateral carotid from diabetic operated rat compensates the hypor-
esponsiveness to angiotensin II in its restenotic ipsilateral carotid,
while the sensory nerves-dependent attenuation of the diabetic
hyperreactivity to angiotensin II in the contralateral artery con-
tributes to restore the local blood ﬂow, previously impaired by
type I-Diabetes in intact rats. Since the blood ﬂow in the restenotic
ipsilateral carotid from diabetic rat is impaired, the restoration of
the blood ﬂow in the contralateral carotid suggest a vasoprotective
pathophysiological signiﬁcance to the sensory neurocompensatory
response triggered by carotid balloon injury during type
I-Diabetes. This adaptive phenomenon may have important impli-
cations in preventing further damage in the cerebral irrigation by
carotid pathways after angioplasty in type I-diabetic subjects.Role of the funding source
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